MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, RCUS has $1,139M in assets. $222M in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
435.93%
Quick Ratio
435.93%
Cash Ratio
96.10%
Unit: Million (M) dollars
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Other noncurrent assets
    • Others
Liabilities Breakdown
    • Common stock and additional paid...
    • Accumulated deficit
    • Other noncurrent liabilities
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
222
Marketable securities
759
Receivable from collaboration partners ( and 6 from a related party)
11
Prepaid expenses and other current assets
15
Total current assets
1,007
Long-term marketable securities
29
Property and equipment, net
40
Other noncurrent assets
63
Total assets
1,139
Accounts payable (24 and to a related party)
42
Deferred revenue (35 and 85 to a related party)
35
Other current liabilities
154
Total current liabilities
231
Deferred revenue, noncurrent (43 and 234 to a related party)
43
Long-term debt
99
Other noncurrent liabilities
135
Common stock and additional paid-in capital 0.0001 par value per share 400.0 shares authorized 125.3 shares in 2025 and 92.2 shares in 2024 issued and outstanding
2,116
Accumulated deficit
-1,485
Total stockholders equity
631
Total liabilities and stockholders equity
1,139
Unit: Million (M) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$759M Cash and cashequivalents$222M Prepaid expenses andother current assets$15M Receivable fromcollaboration partners ( and 6...$11M Total current assets$1,007M Other noncurrentassets$63M Property and equipment,net$40M Long-term marketablesecurities$29M Total assets$1,139M Total liabilities andstockholders equity$1,139M Total stockholdersequity$631M Total currentliabilities$231M Other noncurrentliabilities$135M Long-term debt$99M Deferred revenue,noncurrent (43 and 234 to a...$43M Accumulated deficit-$1,485M Common stock andadditional paid-in capital...$2,116M Other currentliabilities$154M Accounts payable (24 and to a related party)$42M Deferred revenue (35 and85 to a related...$35M

Arcus Biosciences, Inc. (RCUS)

Arcus Biosciences, Inc. (RCUS)